These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 24347770)

  • 1. Parenteral polymyxins: assessing efficacy and safety in critically ill patients with renal dysfunction.
    Sekhri K; Nandha R; Mandal A; Bhasin D; Singh H
    Indian J Pharmacol; 2013; 45(6):608-11. PubMed ID: 24347770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro assessment and multicenter cohort study of comparative nephrotoxicity rates associated with colistimethate versus polymyxin B therapy.
    Phe K; Lee Y; McDaneld PM; Prasad N; Yin T; Figueroa DA; Musick WL; Cottreau JM; Hu M; Tam VH
    Antimicrob Agents Chemother; 2014 May; 58(5):2740-6. PubMed ID: 24566187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymyxin-induced nephrotoxicity and its predictors: a systematic review and meta-analysis of studies conducted using RIFLE criteria of acute kidney injury.
    Sisay M; Hagos B; Edessa D; Tadiwos Y; Mekuria AN
    Pharmacol Res; 2021 Jan; 163():105328. PubMed ID: 33276108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early recovery status and outcomes after sepsis-associated acute kidney injury in critically ill patients.
    Luo X; Yan P; Zhang N; Wang M; Deng Y; Wu T; Wu X; Liu Q; Wang H; Wang L; Kang Y; Duan S
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 May; 47(5):535-545. PubMed ID: 35753723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. To study the clinical efficacy and nephrotoxicity along with the risk factors for acute kidney injury associated with parenteral polymyxin B.
    Nandha R; Sekhri K; Mandal AK
    Indian J Crit Care Med; 2013 Sep; 17(5):283-7. PubMed ID: 24339639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of early initiation of continuous renal replacement therapy based on the KDIGO classification on the prognosis of critically ill patients with acute kidney injury].
    Chen M; Hu B; Li Q; Liu J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2016 Mar; 28(3):246-51. PubMed ID: 29917340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RIFLE-based data collection/management system applied to a prospective cohort multicenter Italian study on the epidemiology of acute kidney injury in the intensive care unit.
    Garzotto F; Piccinni P; Cruz D; Gramaticopolo S; Dal Santo M; Aneloni G; Kim JC; Rocco M; Alessandri E; Giunta F; Michetti V; Iannuzzi M; Belluomo Anello C; Brienza N; Carlini M; Pelaia P; Gabbanelli V; Ronco C;
    Blood Purif; 2011; 31(1-3):159-71. PubMed ID: 21228585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydroxyethyl starch for fluid resuscitation in critically ill patients.
    Bagshaw SM; Chawla LS
    Can J Anaesth; 2013 Jul; 60(7):709-13. PubMed ID: 23604905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and outcome of contrast-associated acute kidney injury assessed with Risk, Injury, Failure, Loss, and End-stage kidney disease (RIFLE) criteria in critically ill patients of medical and surgical intensive care units: a retrospective study.
    Kim MH; Koh SO; Kim EJ; Cho JS; Na SW
    BMC Anesthesiol; 2015; 15():23. PubMed ID: 25780349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risks of Polymyxin B Nephrotoxicity and Its Precursors in the Intensive Care Unit: A Retrospective Cohort Study.
    Özkarakaş H; Özdemir Y; Tosun S; Tekgül ZT; Bilgin MU; Özmuk O; Çalık B
    Cureus; 2023 Aug; 15(8):e44301. PubMed ID: 37779820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative Incidence of Acute Kidney Injury in Critically Ill Patients Receiving Vancomycin with Concomitant Piperacillin-Tazobactam or Cefepime: A Retrospective Cohort Study.
    Hammond DA; Smith MN; Painter JT; Meena NK; Lusardi K
    Pharmacotherapy; 2016 May; 36(5):463-71. PubMed ID: 26952639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence, risk factors and outcome of acute kidney injury in critically ill children - a developing country perspective.
    Rustagi RS; Arora K; Das RR; Pooni PA; Singh D
    Paediatr Int Child Health; 2017 Feb; 37(1):35-41. PubMed ID: 26752169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The safety of polymyxin antibiotics.
    Kelesidis T; Falagas ME
    Expert Opin Drug Saf; 2015; 14(11):1687-701. PubMed ID: 26365594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are there any ways around the exposure-limiting nephrotoxicity of the polymyxins?
    Pogue JM; Ortwine JK; Kaye KS
    Int J Antimicrob Agents; 2016 Dec; 48(6):622-626. PubMed ID: 27876274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of intravenous and aerosolized polymyxins for the treatment of infections in critically ill patients: a review of the recent literature.
    Falagas ME; Kasiakou SK; Tsiodras S; Michalopoulos A
    Clin Med Res; 2006 Jun; 4(2):138-46. PubMed ID: 16809407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-drug versus combination antimicrobial therapy in critically ill patients with hospital-acquired pneumonia and ventilator-associated pneumonia due to Gram-negative pathogens: a multicenter retrospective cohort study.
    Barbier F; Dupuis C; Buetti N; Schwebel C; Azoulay É; Argaud L; Cohen Y; Hong Tuan Ha V; Gainnier M; Siami S; Forel JM; Adrie C; de Montmollin É; Reignier J; Ruckly S; Zahar JR; Timsit JF;
    Crit Care; 2024 Jan; 28(1):10. PubMed ID: 38172969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective evaluation of urine microscopy in septic and non-septic acute kidney injury.
    Bagshaw SM; Haase M; Haase-Fielitz A; Bennett M; Devarajan P; Bellomo R
    Nephrol Dial Transplant; 2012 Feb; 27(2):582-8. PubMed ID: 21669886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical accuracy of RIFLE and Acute Kidney Injury Network (AKIN) criteria for predicting hospital mortality in critically ill patients with multi-organ dysfunction syndrome.
    Ratanarat R; Skulratanasak P; Tangkawattanakul N; Hantaweepant C
    J Med Assoc Thai; 2013 Feb; 96 Suppl 2():S224-31. PubMed ID: 23590046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypomagnesemia as a risk factor for the non-recovery of the renal function in critically ill patients with acute kidney injury.
    Alves SC; Tomasi CD; Constantino L; Giombelli V; Candal R; Bristot Mde L; Topanotti MF; Burdmann EA; Dal-Pizzol F; Fraga CM; Ritter C
    Nephrol Dial Transplant; 2013 Apr; 28(4):910-6. PubMed ID: 22764195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging the distribution of polymyxins in the kidney.
    Yun B; Azad MA; Wang J; Nation RL; Thompson PE; Roberts KD; Velkov T; Li J
    J Antimicrob Chemother; 2015 Mar; 70(3):827-9. PubMed ID: 25377569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.